Karim Saad Temsamani - Mar 1, 2024 Form 4 Insider Report for Cardlytics, Inc. (CDLX)

Role
Chief Executive Officer, Director
Signature
/s/ Nick Lynton, Attorney-in-Fact
Stock symbol
CDLX
Transactions as of
Mar 1, 2024
Transactions value $
-$272,323
Form type
4
Date filed
3/5/2024, 04:24 PM
Previous filing
Jan 3, 2024
Next filing
Mar 25, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDLX Common Stock Options Exercise +84.1K +30.27% 362K Mar 1, 2024 Direct F1
transaction CDLX Common Stock Sale -$272K -34.5K -9.54% $7.89 327K Mar 4, 2024 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDLX Restricted Stock Unit Options Exercise $0 -84.1K -9.09% $0.00 841K Mar 1, 2024 Common Stock 84.1K Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each RSU represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent.
F2 Shares were sold solely to satisfy withholding tax obligations that resulted from the delivery of shares of common stock for RSUs that vested on March 1, 2024. The Reporting Person did not sell shares for any other purpose.
F3 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $7.66 to $8.405, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3).
F4 25% of the RSUs vested on September 1, 2023, with the remaining 75% having vested or vesting in equal amounts over the subsequent three years quarterly thereafter, provided that the Reporting Person remains employed by the Issuer on such vesting date.